Figure 4From: Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial Morning and evening PEFR (L/min): mean change from baseline to week 12, Full Analysis Set . * P-value < 0.01 versus fluticasone/formoterol 100/10 μg b.i.d. combination therapy treatment group. †P-value < 0.001 versus fluticasone/formoterol 100/10 μg b.i.d. combination therapy treatment group. b.i.d. = twice daily; PEFR = peak expiratory flow rate; SE = standard error. Changes from baseline are shown as least-squares mean ± SE for the full analysis set.Back to article page